Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Protease Inhibitors/administration and dosage/therapeutic use"'
Autor:
Lieven Verhoye, Philip Meuleman, Robert Geffers, Thomas Pietschmann, Ali Farhoudi, C. Patrick McClure, Koen Vercauteren, Thomas F. Baumert, Daniel Todt, Sabin Bhuju, Richard J. C. Brown, Eike Steinmann, Tanvi Khera
Publikováno v:
Antiviral Research
Antiviral Research, Elsevier Masson, 2017, 139, pp.129-137. ⟨10.1016/j.antiviral.2017.01.001⟩
Antiviral Research, Elsevier Masson, 2017, 139, pp.129-137. ⟨10.1016/j.antiviral.2017.01.001⟩
PMC5292934; Due to the highly restricted species-tropism of Hepatitis C virus (HCV) a limited number of animal models exist for pre-clinical evaluation of vaccines and antiviral compounds. The human-liver chimeric mouse model allows heterologous chal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e1048d544256c60f80f1e87e33ba4b7
http://eprints.nottingham.ac.uk/40718/
http://eprints.nottingham.ac.uk/40718/